Bortezomib Injection IP 2 mg by Jasgur LifeScience is a lyophilized oncology medicine containing Bortezomib IP. It is supplied as a single-use vial for bolus intravenous or subcutaneous administration, as directed by a qualified oncologist. The product is intended for hospital and institutional use and should be handled according to applicable safety and prescribing guidelines. Jasgur LifeScience supports the supply of quality-focused oncology products for healthcare institutions and pharmaceutical partners, subject to applicable regulatory requirements. Bortezomib Injection 2 mg in india.
Disclaimer: The information provided on this website is for general informational purposes only and is intended exclusively for healthcare professionals, distributors, wholesalers, hospitals, clinics, pharmacies, and other authorized business entities. Jasgur Life Sciences LLP. does not provide medical advice, prescribe or recommend any medication, or promote self-medication. The use of any medicine or treatment should always be based on the advice and judgment of a qualified healthcare professional. Nothing contained on this website shall be construed as an offer, invitation, or solicitation to sell or supply any product in any jurisdiction where such sale, marketing, distribution, or import is restricted, prohibited, or requires prior regulatory approval. Products protected by valid patent rights are not offered for sale in countries where their sale would constitute patent infringement. Importers, distributors, and buyers are solely responsible for ensuring compliance with all applicable laws, regulations, patent rights, and import requirements in their respective jurisdictions.